Proteomics-based vaccine targets annotation and design of subunit and mRNA-based vaccines for Monkeypox virus (MPXV) against the recent outbreakArticle Published on 2023-06-012023-06-10 Journal: Computers in biology and medicine [Category] Fulltext, 원숭이두창, [키워드] Immune simulation Monkeypox mRNA. multi-epitopes Vaccines [DOI] 10.1016/j.compbiomed.2023.106893 PMC 바로가기
An Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza VirusesArticle Published on 2023-04-182023-06-23 Journal: Viruses [Category] 신종인플루엔자, [키워드] H1 Orf virus Swine influenza Vaccines vectored vaccines. [DOI] 10.3390/v15040994 PMC 바로가기
Vaccines against monkeypoxReview Published on 2023-04-062023-06-09 Journal: Medicina clínica [Category] Fulltext, 원숭이두창, [키워드] Monkeypox virus vaccination Vaccines Vacunación vacunas Viruela del mono. [DOI] 10.1016/j.medcli.2023.01.001 PMC 바로가기 [Article Type] Review
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade IIArticle Published on 2023-03-012023-06-09 Journal: Journal of medical virology [Category] 원숭이두창, [키워드] Immunity Monkeypox Neutralizing antibodies Vaccines vaccinia virus. [DOI] 10.1002/jmv.28643 PMC 바로가기
How to stop the bird flu outbreak becoming a pandemicArticle Published on 2023-03-012023-06-01 Journal: Nature [Category] 조류인플루엔자, [키워드] Health care Infection Vaccines Virology. [DOI] 10.1038/d41586-023-00591-3 PMC 바로가기
Rare forms of inflammatory myopathies – part I, generalized formsReview Published on 2023-02-012023-07-11 Journal: Expert review of clinical immunology [Category] COVID19(2023년), [키워드] COVID-19 eosinophils graft versus host disease granuloma immune check point inhibitors myositis Vaccines viruses. [DOI] 10.1080/1744666X.2023.2154656 PMC 바로가기 [Article Type] Review
The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review감염, 중증도, 입원 및 사망률 감소에 대한 COVID-19 백신의 효능 및 효과: 체계적인 검토Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] accelerated approved B.1.1.7 B.1.351 B.1.351 variants COVID-19 COVID-19 pandemic COVID-19 vaccine COVID-19 vaccines database disease transmission effective Effectiveness Efficacy effort growth Hospitalization identify inclusion criteria Infection infections Mortality Pfizer Pfizer/BioNTech populations reduced reducing regimen required Seven severity systematic literature search systematic review Vaccine Vaccine development vaccine. Vaccines variants was performed [DOI] 10.1080/21645515.2022.2027160 PMC 바로가기 [Article Type] Article
Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse급성 재발의 징후를 나타내는 다발성 경화증을 가진 리툭시맙으로 치료받은 사람에서 BBIBP-CorV COVID-19 백신 접종 후 항-NMDA 수용체 항체 검출Article Published on 2022-12-312022-09-12 Journal: Human vaccines & immunotherapeutics [Category] MERS, 진단, [키워드] added administration Anti-N-methyl-D-aspartate receptor Anti-N-Methyl-d-Aspartate receptor antibodies anti-NMDAR antibodies antibody ataxic Autoimmune Autoimmune encephalitis Babinski sign BBIBP-CorV benefit Case report clinician corticosteroid pulse COVID-19 COVID-19 vaccination CSF analysis detection early diagnosis Encephalitis initiated manifestation MRI multiple sclerosis multiple sclerosis. Neurological symptom NMDAR Patient performed Physical examination plaques positive presenting receiving receptor second dose serum Sinopharm Symptoms tested therapy Vaccines worsening [DOI] 10.1080/21645515.2022.2033540 PMC 바로가기 [Article Type] Article
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in ChildrenArticle Published on 2022-12-202023-07-10 Journal: mBio [Category] COVID19(2023년), [키워드] CoronaVac COVID-19 immunogenicity pediatric phase 3 clinical trial Safety SARS-CoV-2 Vaccines variants of concern. [DOI] 10.1128/mbio.01311-22 PMC 바로가기
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19코로나19 중증도에 따라 항체 표적 SARS-CoV-2 에피토프 레퍼토리 달라Article Published on 2022-12-012022-09-11 Journal: Virulence [Category] COVID19(2023년), SARS, 진단, 치료법, [키워드] antibodies antibody Antigen association Asymptomatic asymptomatic individual asymptomatic infection betacoronavirus Betacoronavirus Community convalescent correlated COVID-19 COVID-19 severity develop diagnosed diagnostics disease severity domains Epitopes Evidence evidence of finding FIVE five groups HKU1 Hospitalization IgG IgGs Immunity immunogenic immunogenic peptide individual Infection less MERS-CoV nucleocapsid protein Nucleocapsid proteins OC43 participant pathogenic pathogenic mechanisms peptide peptide array peptides pilot study predicted Protein RBDs reaction Receptor binding domain Region repertoire SARS-CoV RBD SARS-CoV RBDs SARS-CoV-2 SARS-CoV-2 epitope SARS-CoV-2 epitopes seroconverted Seroprevalence seroprevalence. severity severity of COVID-19 symptomatic symptomatic COVID-19 symptomatic infection therapeutic therapeutic antibodies Vaccines Viral with COVID-19 without symptoms [DOI] 10.1080/21505594.2022.2073025 PMC 바로가기 [Article Type] Article